IP Library Granted Patent US 7,304,079
Granted Patent B2
US 7,304,079 · App. 11/531,151 · Granted Dec 4, 2007

Substituted indolealkanoic acids

Assignee: The Institute for Pharmaceutical Discovery, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,304,079
App. No.
11/531,151
Granted
Dec 4, 2007
Kind
B2
Abstract

Disclosed are substituted indolealkanoic acids useful in the treatment of chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds and methods of treatment employing the compounds, as well as methods for their synthesis.

Claims (43)

1. A process for preparing a compound of formula I:

or a pharmaceutically acceptable salt thereof wherein

R a is hydrogen, C 1 -C 6 alkyl, fluoro, or trifluoromethyl;

R 1 is hydrogen, alkyl having 1-6 carbon atoms, halogen, 2-, 3-, or 4- pyridyl, or phenyl, where the phenyl or pyridyl is optionally substituted with up to three groups selected from halogen, hydroxy, C 1 -C 6 alkoxy, C 1 -C 6 alkyl, nitro, amino, or mono- or di(C 1 -C 6 )alkylamino;

R 2 , R 3 , R 4 and R 5 are each independently

hydrogen, halogen, nitro, or an alkyl group of 1-6 carbon atoms unsubstituted or substituted with one or more halogens;

OR 7 , SR 7 , S(O)R 7 , S(O) 2 N(R 7 ) 2 , C(O)N(R 7 ) 2 , or N(R 7 ) 2 , wherein each R 7 is independently hydrogen, an alkyl group of 1-6 carbon atoms unsubstituted or substituted with one or more halogens, or benzyl, where the phenyl portion is unsubstituted or substituted with up to three groups independently selected from halogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, amino, and mono or di(C 1 -C 6 )alkylamino;

phenyl or heteroaryl, each of which phenyl or heteroaryl is unsubstituted or substituted with up to three groups independently selected from halogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, amino, and mono- or di(C 1 -C 6 )alkylamino;

phenoxy where the phenyl portion is unsubstituted or substituted with up to three groups independently selected from halogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, amino, and mono or di(C 1 -C 6 )alkylamino; or

a group of the formula

 where

J is a bond, CH 2 , oxygen, or nitrogen; and

each r is independently 2 or 3;

R 6 is hydroxy, benzyloxy, di(C 1 -C 6 )alkylaminoethyloxy, acetoxymethyloxy, pivaloyloxymethyloxy, phthalidoyloxy, ethoxycarbonyloxyethyloxy, 5-methyl-2-oxo-1,3-dioxol-4-yl methyloxy, C 1 -C 6 alkoxy unsubstituted or substituted by N-morpholino, or di(C 1 -C 6 )alkylamino;

and Ar represents benzothiazolyl, where the benzo portion is unsubstituted or substituted by one of iodo, cyano, nitro, perfluoroethyl, trifluoroacetyl, or (C 1 -C 6 )alkanoyl, one or two of fluoro, chloro, bromo, hydroxy, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkylthio, trifluoromethoxy, trifluoromethylthio, (C 1 -C 6 )alkylsulfinyl, (C 1 -C 6 )alkylsulfonyl or trifluoromethyl, or two fluoro or two trifluoromethyl with one hydroxy or one (C 1 -C 6 )alkoxy, or one or two fluoro and one trifluoromethyl, or three fluoro;

comprising

(a) heating a solution containing (i) a protected acid of formula V

 where

R a , R 1 , R 2 , R 3 , R 4 , and R 5 are as defined above; and

Ar 2 is unsubstituted phenyl or phenyl substituted by one of iodo, cyano, nitro, perfluoroethyl, trifluoroacetyl, or (C 1 -C 6 )alkanoyl, one or two of fluoro, chloro, bromo, hydroxy, (C 1 -C 6 ) alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkylthio, trifluoromethoxy, trifluoromethylthio, (C 1 -C 6 )alkylsulfinyl, (C 1 -C 6 )alkylsulfonyl or trifluoromethyl, or two fluoro or two trifluoromethyl with one hydroxy or one (C 1 -C 6 )alkoxy, or one or two fluoro and one trifluoromethyl, or three fluoro;

R 61 is benzyloxy, di(C 1 -C 6 )alkylaminoethyloxy, acetoxymethyloxy, pivaloyloxymethyloxy, phthalidoyloxy, ethoxycarbonyloxyethyloxy, 5-methyl-2oxo-1,3-dioxol-4-yl methyloxy, C 1 -C 6 alkoxy unsubstituted or substituted by N-morpholino, or di(C 1 -C 6 )alkylamino;

and (ii) potassium ferricyanide or sodium hydride;

to produce a protected acid of Formula VII

 and

(b) optionally removing the protecting group from the protected acid VII.

2. The process of claim 1 , wherein the protected acid is prepared according to the process comprising,

contacting a compound of the formula,

with P 2 S 5 .

3. The process of claim 2 , wherein the compound of the formula,

is prepared according to the process comprising,

contacting a compound of the formula,

with a compound of the formula, HNAr 2 , in the presence of a amide coupling reagent.

4. The process of claim 3 , wherein the amide coupling reagent is 1,3-dicyclohexylcarbodiimide.

5. The process of claim 2 , wherein the compound of the formula,

is prepared according to the process comprising,

contacting a compound of the formula,

with an acid chloride forming reagent to produce an acid chloride intermediate; and

contacting the acid chloride intermediate with a compound of the formula, HNAr 2 .

6. The process of claim 2 , wherein the compound of the formula

is prepared according to the process comprising,

contacting a compound of the formula,

with an mixed anhydride forming reagent to produce a mixed anhydride intermediate; and

contacting the mixed anhydride intermediate with a compound of the formula, HNAr 2 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2011
From: THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY, LLC
To: ALINEA PHARMACEUTICALS, INC.
Reel/Frame 026357/0203 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2011
From: JONES, MICHAEL LEE; GUNN, DAVID; JONES, JOHN HOWARD; VAN ZANDT, MICHAEL C.
To: THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY, INC.
Reel/Frame 026337/0206 →
Continuity (6)
Continuation 1083272400 · Apr 27, 2004
Continuation 1018586300 · Jun 28, 2002
Continuation 0981880800 · Mar 27, 2001
Continuation 0928228000 · Mar 31, 1999
Provisional Application 6008014300 · Mar 31, 1998
Related Publication 20070093530A1 · Apr 26, 2007